Theranostic DNAzymes

DNAzymes are catalytically active DNA molecules that are obtained via in vitro selection. RNA-cleaving DNAzymes have attracted significant attention for both therapeutic and diagnostic applications due to their excellent programmability, stability, and activity. They can be designed to cleave a spec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Theranostics 2017-01, Vol.7 (4), p.1010-1025
Hauptverfasser: Zhou, Wenhu, Ding, Jinsong, Liu, Juewen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1025
container_issue 4
container_start_page 1010
container_title Theranostics
container_volume 7
creator Zhou, Wenhu
Ding, Jinsong
Liu, Juewen
description DNAzymes are catalytically active DNA molecules that are obtained via in vitro selection. RNA-cleaving DNAzymes have attracted significant attention for both therapeutic and diagnostic applications due to their excellent programmability, stability, and activity. They can be designed to cleave a specific mRNA to down-regulate gene expression. At the same time, DNAzymes can sense a broad range of analytes. By combining these two functions, theranostic DNAzymes are obtained. This review summarizes the progress of DNAzyme for theranostic applications. First, selection of DNAzymes is briefly introduced, and some representative DNAzymes related to biological applications are summarized. Then, the applications of DNAzyme for RNA cleaving are reviewed. DNAzymes have been used to cleave RNA for treating various diseases, such as viral infection, cancer, inflammation and atherosclerosis. Several formulations have entered clinical trials. Next, the use of DNAzymes for detecting metal ions, small molecules and nucleic acids related to disease diagnosis is summarized. Finally, the theranostic applications of DNAzyme are reviewed. The challenges to be addressed include poor DNAzyme activity under biological conditions, mRNA accessibility, delivery, and quantification of gene expression. Possible solutions to overcome these challenges are discussed, and future directions of the field are speculated.
doi_str_mv 10.7150/thno.17736
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5381262</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1884890776</sourcerecordid><originalsourceid>FETCH-LOGICAL-c378t-5a5c9fd02f6519c6e88b946f33fd0cd6ef2f939ca04e12ab98f8255e9b214d0b3</originalsourceid><addsrcrecordid>eNpVkMtLw0AQxhdRbKm9iGfxKELqPrKvi1DqE4pe6nnZbHZNJMnW3aRQ_3pTW0udywzz_fhm-AA4R3DCEYW3bdH4CeKcsCMwRIKIhLMUHh_MAzCO8RP2lUIskTwFA9xrGHE8BBeLwgbd-NiW5ur-dfq9rm08AydOV9GOd30E3h8fFrPnZP729DKbzhNDuGgTqqmRLofYMYqkYVaITKbMEdIvTc6sw04SaTRMLcI6k8IJTKmVGUZpDjMyAndb32WX1TY3tmmDrtQylLUOa-V1qf4rTVmoD79SlAiEGe4NrncGwX91NraqLqOxVaUb67uokBCpkJBz1qM3W9QEH2Owbn8GQbVJUm2SVL9J9vDl4WN79C838gOoC25q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1884890776</pqid></control><display><type>article</type><title>Theranostic DNAzymes</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Zhou, Wenhu ; Ding, Jinsong ; Liu, Juewen</creator><creatorcontrib>Zhou, Wenhu ; Ding, Jinsong ; Liu, Juewen</creatorcontrib><description>DNAzymes are catalytically active DNA molecules that are obtained via in vitro selection. RNA-cleaving DNAzymes have attracted significant attention for both therapeutic and diagnostic applications due to their excellent programmability, stability, and activity. They can be designed to cleave a specific mRNA to down-regulate gene expression. At the same time, DNAzymes can sense a broad range of analytes. By combining these two functions, theranostic DNAzymes are obtained. This review summarizes the progress of DNAzyme for theranostic applications. First, selection of DNAzymes is briefly introduced, and some representative DNAzymes related to biological applications are summarized. Then, the applications of DNAzyme for RNA cleaving are reviewed. DNAzymes have been used to cleave RNA for treating various diseases, such as viral infection, cancer, inflammation and atherosclerosis. Several formulations have entered clinical trials. Next, the use of DNAzymes for detecting metal ions, small molecules and nucleic acids related to disease diagnosis is summarized. Finally, the theranostic applications of DNAzyme are reviewed. The challenges to be addressed include poor DNAzyme activity under biological conditions, mRNA accessibility, delivery, and quantification of gene expression. Possible solutions to overcome these challenges are discussed, and future directions of the field are speculated.</description><identifier>ISSN: 1838-7640</identifier><identifier>EISSN: 1838-7640</identifier><identifier>DOI: 10.7150/thno.17736</identifier><identifier>PMID: 28382172</identifier><language>eng</language><publisher>Australia: Ivyspring International Publisher</publisher><subject>Animals ; Biological Therapy - methods ; Biomedical Research - trends ; Diagnostic Tests, Routine - methods ; DNA, Catalytic - metabolism ; Humans ; Review ; RNA - metabolism ; Theranostic Nanomedicine - methods</subject><ispartof>Theranostics, 2017-01, Vol.7 (4), p.1010-1025</ispartof><rights>Ivyspring International Publisher 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c378t-5a5c9fd02f6519c6e88b946f33fd0cd6ef2f939ca04e12ab98f8255e9b214d0b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381262/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381262/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28382172$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhou, Wenhu</creatorcontrib><creatorcontrib>Ding, Jinsong</creatorcontrib><creatorcontrib>Liu, Juewen</creatorcontrib><title>Theranostic DNAzymes</title><title>Theranostics</title><addtitle>Theranostics</addtitle><description>DNAzymes are catalytically active DNA molecules that are obtained via in vitro selection. RNA-cleaving DNAzymes have attracted significant attention for both therapeutic and diagnostic applications due to their excellent programmability, stability, and activity. They can be designed to cleave a specific mRNA to down-regulate gene expression. At the same time, DNAzymes can sense a broad range of analytes. By combining these two functions, theranostic DNAzymes are obtained. This review summarizes the progress of DNAzyme for theranostic applications. First, selection of DNAzymes is briefly introduced, and some representative DNAzymes related to biological applications are summarized. Then, the applications of DNAzyme for RNA cleaving are reviewed. DNAzymes have been used to cleave RNA for treating various diseases, such as viral infection, cancer, inflammation and atherosclerosis. Several formulations have entered clinical trials. Next, the use of DNAzymes for detecting metal ions, small molecules and nucleic acids related to disease diagnosis is summarized. Finally, the theranostic applications of DNAzyme are reviewed. The challenges to be addressed include poor DNAzyme activity under biological conditions, mRNA accessibility, delivery, and quantification of gene expression. Possible solutions to overcome these challenges are discussed, and future directions of the field are speculated.</description><subject>Animals</subject><subject>Biological Therapy - methods</subject><subject>Biomedical Research - trends</subject><subject>Diagnostic Tests, Routine - methods</subject><subject>DNA, Catalytic - metabolism</subject><subject>Humans</subject><subject>Review</subject><subject>RNA - metabolism</subject><subject>Theranostic Nanomedicine - methods</subject><issn>1838-7640</issn><issn>1838-7640</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkMtLw0AQxhdRbKm9iGfxKELqPrKvi1DqE4pe6nnZbHZNJMnW3aRQ_3pTW0udywzz_fhm-AA4R3DCEYW3bdH4CeKcsCMwRIKIhLMUHh_MAzCO8RP2lUIskTwFA9xrGHE8BBeLwgbd-NiW5ur-dfq9rm08AydOV9GOd30E3h8fFrPnZP729DKbzhNDuGgTqqmRLofYMYqkYVaITKbMEdIvTc6sw04SaTRMLcI6k8IJTKmVGUZpDjMyAndb32WX1TY3tmmDrtQylLUOa-V1qf4rTVmoD79SlAiEGe4NrncGwX91NraqLqOxVaUb67uokBCpkJBz1qM3W9QEH2Owbn8GQbVJUm2SVL9J9vDl4WN79C838gOoC25q</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Zhou, Wenhu</creator><creator>Ding, Jinsong</creator><creator>Liu, Juewen</creator><general>Ivyspring International Publisher</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170101</creationdate><title>Theranostic DNAzymes</title><author>Zhou, Wenhu ; Ding, Jinsong ; Liu, Juewen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c378t-5a5c9fd02f6519c6e88b946f33fd0cd6ef2f939ca04e12ab98f8255e9b214d0b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Biological Therapy - methods</topic><topic>Biomedical Research - trends</topic><topic>Diagnostic Tests, Routine - methods</topic><topic>DNA, Catalytic - metabolism</topic><topic>Humans</topic><topic>Review</topic><topic>RNA - metabolism</topic><topic>Theranostic Nanomedicine - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhou, Wenhu</creatorcontrib><creatorcontrib>Ding, Jinsong</creatorcontrib><creatorcontrib>Liu, Juewen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Theranostics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhou, Wenhu</au><au>Ding, Jinsong</au><au>Liu, Juewen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Theranostic DNAzymes</atitle><jtitle>Theranostics</jtitle><addtitle>Theranostics</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>7</volume><issue>4</issue><spage>1010</spage><epage>1025</epage><pages>1010-1025</pages><issn>1838-7640</issn><eissn>1838-7640</eissn><abstract>DNAzymes are catalytically active DNA molecules that are obtained via in vitro selection. RNA-cleaving DNAzymes have attracted significant attention for both therapeutic and diagnostic applications due to their excellent programmability, stability, and activity. They can be designed to cleave a specific mRNA to down-regulate gene expression. At the same time, DNAzymes can sense a broad range of analytes. By combining these two functions, theranostic DNAzymes are obtained. This review summarizes the progress of DNAzyme for theranostic applications. First, selection of DNAzymes is briefly introduced, and some representative DNAzymes related to biological applications are summarized. Then, the applications of DNAzyme for RNA cleaving are reviewed. DNAzymes have been used to cleave RNA for treating various diseases, such as viral infection, cancer, inflammation and atherosclerosis. Several formulations have entered clinical trials. Next, the use of DNAzymes for detecting metal ions, small molecules and nucleic acids related to disease diagnosis is summarized. Finally, the theranostic applications of DNAzyme are reviewed. The challenges to be addressed include poor DNAzyme activity under biological conditions, mRNA accessibility, delivery, and quantification of gene expression. Possible solutions to overcome these challenges are discussed, and future directions of the field are speculated.</abstract><cop>Australia</cop><pub>Ivyspring International Publisher</pub><pmid>28382172</pmid><doi>10.7150/thno.17736</doi><tpages>16</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1838-7640
ispartof Theranostics, 2017-01, Vol.7 (4), p.1010-1025
issn 1838-7640
1838-7640
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5381262
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access
subjects Animals
Biological Therapy - methods
Biomedical Research - trends
Diagnostic Tests, Routine - methods
DNA, Catalytic - metabolism
Humans
Review
RNA - metabolism
Theranostic Nanomedicine - methods
title Theranostic DNAzymes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T00%3A07%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Theranostic%20DNAzymes&rft.jtitle=Theranostics&rft.au=Zhou,%20Wenhu&rft.date=2017-01-01&rft.volume=7&rft.issue=4&rft.spage=1010&rft.epage=1025&rft.pages=1010-1025&rft.issn=1838-7640&rft.eissn=1838-7640&rft_id=info:doi/10.7150/thno.17736&rft_dat=%3Cproquest_pubme%3E1884890776%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1884890776&rft_id=info:pmid/28382172&rfr_iscdi=true